Nymox Pharma (NYMX) Stock: Skyrocketing on Positive Study Results

By |August 24th, 2016|

Nymox Pharmaceutical Corporation (NASDAQ: NYMX)

Nymox Pharmaceutical Corporation is having an incredible day in the market today, and for good reason. The company announced successful results from a key Phase 3 clinical trial. Today, we’ll talk about the results, how the stock reacted to the news, and what we can expect to see from NYMX […]